Preferred Label : Tirzepatide;
MeSH definition : A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1
(GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES
MELLITUS.;
UNII : OYN3CCI6QE;
Origin ID : D000098860;
UMLS CUI : C5139934;
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
Manual NTBT mappings (CISMeF)
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1
(GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES
MELLITUS.
https://www.usherbrooke.ca/baladocritique/archives/episode-67-etude-surmount-osa
2025
Canada
sound
Tirzepatide
apnea
sleep apnea, nos
episode of
osteosarcoma
obstruction, nos
sleep apnea, obstructive
sleep
breath holding
data collection
tirzepatide
---
https://www.cbip.be/fr/articles/4669?folia=4667
2025
false
false
false
Belgium
French
drug information
journal article
comparative effectiveness research
obesity
Tirzepatide
Glucagon-Like Peptide-1 Receptor Agonists
semaglutide
treatment outcome
---
https://ansm.sante.fr/actualites/analogues-du-glp-1-et-obesite-nous-prenons-des-mesures-pour-securiser-leur-utilisation-en-france
2025
false
false
false
France
French
patient safety
Glucagon-Like Peptide-1 Receptor Agonists
obesity
france
Drug Misuse
prescription drug misuse
drug prescriptions
critical pathways
semaglutide
pharmacovigilance note
guideline
Tirzepatide
Liraglutide
legislation, pharmacy
---
https://www.has-sante.fr/jcms/p_3776029/fr/mounjaro-tirzepatide-obesite
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
Tirzepatide
obesity
tirzepatide
Glucagon-Like Peptide-1 Receptor Agonists
adult
evaluation of the transparency committee
---
https://www.cfp.ca/content/71/11-12/e278
2025
false
false
false
Canada
Tirzepatide
weight loss
Tirzepatide
journal article
---
https://www.has-sante.fr/jcms/p_3538387/fr/mounjaro-tirzepatide-diabete-de-type-2
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
hypoglycemic agents
tirzepatide
adult
drug therapy, combination
injections, subcutaneous
metformin
insulin
Sulfonylurea Antidiabetic Agent
Tirzepatide
evaluation of the transparency committee
diabetes mellitus, type 2
tirzepatide
---
https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
tirzepatide
hypoglycemic agents
hypoglycemic agents
adult
diabetes mellitus, type 2
injections, subcutaneous
gastric inhibitory polypeptide
glucagon-like peptide 1
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Tirzepatide
Tirzepatide
obesity
Glucagon-Like Peptide-1 Receptor Agonists
Glucagon-Like Peptide-1 Receptor Agonists
---